You just read:

PTC Therapeutics Announces Results from Pivotal Phase 3 Clinical Trial of Ataluren in Patients Living with Nonsense Mutation Cystic Fibrosis

News provided by

PTC Therapeutics, Inc.

Mar 02, 2017, 08:00 ET